# Screening for Cancer in Patients With Unprovoked VTE

Study · id `cardio:ct-nct03937583` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT03937583](<https://clinicaltrials.gov/study/NCT03937583>), retrieved 31 October 2026. No person wrote or checked this page.

Also called: NCT03937583

Browse, organ or system: Heart; Blood vessels  
Browse, condition area: Coronary and vascular disease  

## In plain language

A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 650 participants.

## Technical summary

Registry record NCT03937583. Randomized; no masking; primary purpose diagnostic. Start 2019-10-23 (actual); primary completion 2023-12-01 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose diagnostic
- Phase: Phase 4
- Enrolled: 650 participants (planned count; ClinicalTrials.gov record NCT03937583, source copy `cardio:ctgov-nct03937583-2021-12-09`, retrieved 2026-10-31)
- Started: 2019-10-23 (actual) (ClinicalTrials.gov record NCT03937583, source copy `cardio:ctgov-nct03937583-2021-12-09`, retrieved 2026-10-31)
- Primary completion: 2023-12-01 (anticipated) (ClinicalTrials.gov record NCT03937583, source copy `cardio:ctgov-nct03937583-2021-12-09`, retrieved 2026-10-31)
- Completion: 2023-12-31 (anticipated) (ClinicalTrials.gov record NCT03937583, source copy `cardio:ctgov-nct03937583-2021-12-09`, retrieved 2026-10-31)
- Countries: Spain (ClinicalTrials.gov record NCT03937583, source copy `cardio:ctgov-nct03937583-2021-12-09`, retrieved 2026-10-31)
- Care setting: Not reported
- Registry status: "UNKNOWN" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct03937583-2021-12-09`, retrieved 2026-10-31)

## The registry's words

- Brief title: Screening for Cancer in Patients With Unprovoked VTE
- Acronym: SOME-RIETE
- Condition: Venous Thromboembolic Disease
- Condition: Respiratory Disease
- Condition: Pulmonary Disease
- Condition: Deep Venous Thrombosis
- Condition: Pulmonary Embolism
- Condition: Screening
- Condition: Undefined
- Intervention (Drug): Fludeoxyglucose 18F
- Lead sponsor: Fundación Pública Andaluza para la gestión de la Investigación en Sevilla
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Deep vein thrombosis (`cardio:deep-vein-thrombosis`)
- Registry condition terms include this condition: Pulmonary embolism (`cardio:pulmonary-embolism`)

## Provenance

Content hash: 4379ed19246b2761ce36b8471c8b36efaf91c80e5d57bb59735b2a66225c2706
Last substantive edit: 2026-10-31
Evidence last checked: Not recorded
